These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21458664)

  • 21. [Paradigm Transformation of Cancer Research and Development, Treatment, and Clinical Trials toward Total Cure - The Role of ARO].
    Kojima S; Fukushima M
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):927-34. PubMed ID: 27539033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical approaches to the discovery and development of cancer therapies.
    Neidle S; Thurston DE
    Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 24. Translational study in cancer research.
    Saijo N
    Intern Med; 2002 Oct; 41(10):770-3. PubMed ID: 12412993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer drug discovery using chemical genomics.
    Sehgal A
    Curr Med Chem; 2003 May; 10(9):749-55. PubMed ID: 12678778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
    Walker K
    IDrugs; 2007 Aug; 10(8):517-9. PubMed ID: 17665321
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug Delivery in Cancer Therapy, Quo Vadis?
    Lu ZR; Qiao P
    Mol Pharm; 2018 Sep; 15(9):3603-3616. PubMed ID: 29553749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development.
    Hollebecque A; Massard C; Soria JC
    Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change or be changed: reflections of the workshop 'Future in Medicinal Chemistry'.
    Brenk R; Rauh D
    Bioorg Med Chem; 2012 Jun; 20(12):3695-7. PubMed ID: 22607881
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into drug resistance in cancer.
    Ojima I; Ferlini C
    Chem Biol; 2003 Jul; 10(7):583-4. PubMed ID: 12890528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Therapeutics, Molecular Targets, Pharmacology and Clinical Applications--First International Conference 19-21 February 2004, Florence, Italy.
    Roberts J
    IDrugs; 2004 Apr; 7(4):301-5. PubMed ID: 15057630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolving potential of companion diagnostics.
    Khoury JD
    Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving paradigm of cancer trials.
    Kummar S
    Nat Rev Drug Discov; 2018 Apr; 17(4):225-226. PubMed ID: 29269944
    [No Abstract]   [Full Text] [Related]  

  • 35. A target or a demi-target.
    Mok TS
    Clin Lung Cancer; 2010 May; 11(3):147-8. PubMed ID: 20439189
    [No Abstract]   [Full Text] [Related]  

  • 36. Xanthus Life Sciences. Fine-tuning personalized medicine.
    McCarthy AA
    Chem Biol; 2003 Aug; 10(8):673-4. PubMed ID: 12954325
    [No Abstract]   [Full Text] [Related]  

  • 37. Designing transformative clinical trials in the cancer genome era.
    Sleijfer S; Bogaerts J; Siu LL
    J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010-2014).
    Tanaka M; Roberts JM; Qi J; Bradner JE
    Pharm Pat Anal; 2015; 4(4):261-84. PubMed ID: 26174566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1.
    Walker K; Kibble A; Shumoogam J
    IDrugs; 2007 Aug; 10(8):513-6. PubMed ID: 17665320
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidermal growth factor receptor inhibitors: current status and future directions.
    Chen HX; Cleck JN; Coelho R; Dancey JE
    Curr Probl Cancer; 2009; 33(4):245-94. PubMed ID: 20082842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.